ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2056

Effectiveness of a Focused Educational Intervention in Improving the Supplementation of Vitamin D Deficiency and Insufficiency

Candice Low1, Richard Conway2, Gaye Cunnane3, Michele Doran3 and Finbar (Barry) D. O'Shea1, 1Rheumatology Dept, St James's Hospital, Dublin, Ireland, 2Rheumatology, St James's Hospital, Dublin, Ireland, 3Dept of Rheumatology, St James's Hospital, Dublin, Ireland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Education, medical and vitamins

  • Tweet
  • Email
  • Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Vitamin D deficiency and insufficiency are important clinical states with the potential for adverse skeletal and non-skeletal consequences. In our experience the management of these states is frequently suboptimal. Focused educational initiatives are a proven means to improve patient care. The aim of this study was to evaluate the effectiveness of a focused educational intervention in improving the supplementation of patients with vitamin D deficiency and insufficiency.

Methods:

A prospective study of 100 consecutive patients in the general rheumatology clinic with 25-hydroxyvitamin D deficiency or insufficiency (as defined as <30ng/ml) measured within the previous year was undertaken. A systematic literature review was performed and a consensus decision was made to supplement all patients with 25-hydroxyvitamin D <30ng/ml with 2000 units of vitamin D a day, with repeat testing at the next visit to ensure adequate but not excess supplementation. Following this a teaching session was held educating members of the multi-disciplinary team on the importance of vitamin D supplementation and reminders to supplement patients were placed in the clinic offices. Following the education intervention a further prospective study of 100 consecutive patients with 25-hydroxyvitamin D <30ng/ml measured within the previous year was performed.

Results:

In the initial 100 patients screened, 25% were male, mean age was 56 years. Primary diagnosis was inflammatory arthritis (IA) in 62%, connective tissue disease (CTD) in 14%, osteoarthritis (OA) in 12% and other conditions in 12%. 18% had known osteoporosis and 13% had previous fractures. Mean 25-hydroxyvitamin D was 17.8 ng/ml. 20 patients had 25-hydroxyvitamin D <12ng/ml, 40 had 25-hydroxyvitamin D 12-20ng/ml, 40 had 25-hydroxyvitamin D 20-30ng/ml. Pre-education only 28 patients had additional vitamin D prescribed as a result. Following the educational intervention, in the population screened 25% were male, mean age was 55 years. Primary diagnosis was IA in 47%, OA in 16%, CTD in 11% and other conditions in 26%. 15% had known osteoporosis and 12% had previous fractures. Mean 25-hydroxyvitamin D was 16.4 ng/ml. 31 patients had 25-hydroxyvitamin D <12ng/ml, 39 had 25-hydroxyvitamin D 12-20ng/ml, 30 had 25-hydroxyvitamin D 20-30ng/ml. As a consequence of our educational intervention, 80 patients had additional vitamin D prescribed. The change in vitamin D prescriptions following the educational intervention is shown in figure 1.

Conclusion:                                    

A focused educational intervention has the potential to improve vitamin D supplementation and patient care in the management of low vitamin D states. Failure to identify and adequately treat vitamin D deficiency has the potential for serious adverse consequences for our patients.

Figure 1: % of Patients Prescribed, and Dose Prescribed of, Vitamin D Pre and Post an Educational Initiative


Disclosure:

C. Low,

Roche Pharmaceuticals,

2,

UCB Pharma,

2,

Merck Pharmaceuticals,

7;

R. Conway,

Roche Pharmaceuticals,

2,

UCB Pharma,

2,

Merck Pharmaceuticals,

7;

G. Cunnane,
None;

M. Doran,
None;

F. D. O’Shea,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-a-focused-educational-intervention-in-improving-the-supplementation-of-vitamin-d-deficiency-and-insufficiency/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology